Wnt5a / planar cell polarity signaling pathway in urothelial carcinoma, a potential prognostic biomarker

Mark Saling; Jordan K. Duckett; Ian Ackers; Karen Coschigano; Scott Jenkinson; Ramiro Malgor

doi:10.18632/oncotarget.15877

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Wnt5a / planar cell polarity signaling pathway in urothelial carcinoma, a potential prognostic biomarker

Mark Saling, Jordan K. Duckett, Ian Ackers, Karen Coschigano, Scott Jenkinson and Ramiro Malgor _

PDF | HTML | How to cite

Oncotarget. 2017; 8:31655-31665. https://doi.org/10.18632/oncotarget.15877

Metrics: PDF 2041 views | HTML 2286 views | ?

Abstract

Mark Saling1, Jordan K. Duckett1, Ian Ackers1, Karen Coschigano1,2,3, Scott Jenkinson4 and Ramiro Malgor1,2,3

1Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA

2Interdisciplinary Program in Molecular and Cellular Biology, Ohio University, Athens, Ohio, USA

3The Diabetes Institute of Ohio University, Athens, Ohio, USA

4University Medical Associates, Inc., Pathology, Athens, Ohio, USA

Correspondence to:

Ramiro Malgor, email: [email protected]

Keywords: urothelial carcinoma, bladder, Wnt5a, epithelial mesenchymal transition, biomarker

Received: August 25, 2016 Accepted: February 01, 2017 Published: March 03, 2017

ABSTRACT

Bladder cancer is the fourth most common cancer in men and the most common malignancy of the urinary tract. Bladder cancers detected at an early stage have a very high five-year survival rate, but when detected after local metastasis the rate is only about 50%. Our group recently reported a positive correlation between the expression of Wnt5a, a member of the Wnt proteins family, and histopathological grade and stage of urothelial carcinoma (UC). The objective of this study was to analyze UC cases reported in Athens, Ohio and investigate the major components of Wnt5a / planar cell polarity (PCP) signaling pathway in UC human tissue samples and UC cell lines.

Formalin fixed and paraffin embedded transurethral resection tissues were immunostained for Wnt5a, Ror-2, CTHRC1 and E-cadherin. In addition, in vitro studies using UC cell lines were investigated for Wnt5a/PCP signaling and epithelial mesenchymal transition (EMT) gene expression. The IHC results showed a correlation between the expression of Wnt5a, Ror2 and CTHRC1 with high histological grade of the tumor, while E-cadherin showed an opposite trend of expression. Real time RT-PCR results showed that RNA expression of the Wnt5a/ PCP pathway genes vary in low and high grade UC cell lines and that the high grade cell lines exhibited signs of EMT.

These findings support that Wnt5a-Ror2 signaling plays a role in UC, support the potential use of Wnt5a as a prognostic marker and provide evidence that Wnt5a signaling may be used as an effective molecular target for novel therapeutic tools.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15877

Publication Alerts

Research Papers:

Wnt5a / planar cell polarity signaling pathway in urothelial carcinoma, a potential prognostic biomarker

Abstract